Document Detail


Flunarizine i.v. in the acute treatment of common or classical migraine attacks--a placebo-controlled double blind trial.
MedLine Citation:
PMID:  2647666     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The efficacy and tolerance of 20 mg flunarizine i.v. were tested in comparison with placebo in a multicentre randomised double-blind trial in the acute treatment of migraine attacks. Sixty case reports were included in the evaluation; 31 patients were treated with flunarizine and 29 with placebo. Flunarizine proved to be significantly superior in its effect on the intensity of pain and the typical concomitant symptoms of the attacks. Patients were classed as responders who displayed a reduction in pain intensity by at least 50% within 60 minutes after the administration of flunarizine. 23 patients (= 74.2%) were responders, including 11 patients being without pain after 60 minutes. In the placebo group the responder rate was 27.6% The fact that both groups were comparable in all respects should be emphasized. The tolerance of intravenously administered flunarizine was excellent and corresponded to that of placebo. Apart from a sedative effect reported by 9 patients there were no side-effects. The circulatory conditions remained largely stable. The result of this study seems to indicate that an intravenous injection of 20 mg flunarizine might represent a genuine alternative, and as regards tolerance even a superior one, to the parenteral administration of ergotamine in migraine attacks.
Authors:
D Soyka; Z Taneri; W Oestreich; R Schmidt
Related Documents :
18713156 - A double-blind, randomized trial of low-dose topiramate vs propranolol in migraine prop...
15697326 - Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute trea...
19114966 - The effect of vitamin e on the treatment of menstrual migraine.
19674596 - Chronic migraine and chiropractic rehabilitation: a case report.
22698636 - Psychological distress and in vitro fertilization outcome.
22738716 - Efficacy of light therapy for perinatal depression: a review.
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Headache     Volume:  29     ISSN:  0017-8748     ISO Abbreviation:  Headache     Publication Date:  1989 Jan 
Date Detail:
Created Date:  1989-05-11     Completed Date:  1989-05-11     Revised Date:  2009-02-02    
Medline Journal Info:
Nlm Unique ID:  2985091R     Medline TA:  Headache     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  21-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Clinical Trials as Topic
Double-Blind Method
Female
Flunarizine / administration & dosage,  adverse effects,  therapeutic use*
Humans
Injections, Intravenous
Male
Middle Aged
Migraine Disorders / drug therapy*
Chemical
Reg. No./Substance:
52468-60-7/Flunarizine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of inflammation in CW Nd:YAG contact transscleral photocoagulation and cryopexy.
Next Document:  Non-invasive treatment of vascular and muscle contraction headache: a comparative longitudinal clini...